Biosensors, Journal Year: 2025, Volume and Issue: 15(4), P. 257 - 257

Published: April 17, 2025

Innovative biosensor technologies are revolutionizing cancer detection by offering non-invasive, sensitive, and rapid diagnostic tools, addressing the limitations of conventional screening. Non-invasive samples like breath, saliva, urine, sweat, analyzed using advanced electronic nose systems AI, show promise for early frequent monitoring, though validation is needed. AI integration enhances data analysis personalization. While blood-based methods remain gold standard, combining them with less invasive sample types saliva or sensitive techniques, a promising direction. Conventional (mammography, MRI, etc.) offer proven efficacy, but costly invasive. biosensors reduced infrastructure needs, lower costs, patient-friendly sampling. However, challenges in validation, standardization, low biomarker concentrations. Integrating both methodologies could create comprehensive framework, reliability accessibility. Future research should focus on robust development, expanding application to other cancers, exploring less-studied improving affordability wider adoption, especially resource-limited settings. The future lies integrating diverse approaches more specific, screening, outcomes.

Language: Английский